Discuss the significance of harmonising quality standards for medicinal plants under initiatives like 'One Herb, One Standard'. How does this affect the credibility and export competitiveness of India's traditional medicine sector?

'One Herb, One Standard' is an inter-ministerial initiative under which the Pharmacopoeia Commission for Indian Medicine & Homoeopathy (PCIM&H, Ministry of Ayush) and the Indian Pharmacopoeia Commission (IPC, Ministry of Health & Family Welfare) jointly develop harmonised monographs for medicinal plants, so that one herb no longer carries divergent quality standards in different pharmacopoeias [1].

Significance of harmonisation

• Ends regulatory fragmentation: the same botanical earlier carried different identity, purity and assay parameters across the Ayurvedic, Siddha, Unani and Homoeopathic Pharmacopoeias and the Indian Pharmacopoeia; the Ministry of Ayush is harmonising these into a single reference [2].
• A working model of inter-ministerial convergence: a joint committee selects plants and marker compounds while PCIM&H retains sole publication authority, enabling collaboration without turf conflict [1]. The MoU of 30 August 2022 was renewed in August 2026 for a further three years [3].
• Scientific validation: monographs fix measurable markers, moving traditional medicine from assertion to evidence; 50 monographs were completed in the first phase [3].

Credibility of the sector

• Uniform, testable specifications give regulators, physicians and consumers the same quality assurance irrespective of the system prescribing the herb, curbing adulteration and substitution.
• Each monograph is designed to carry Indian standards alongside international quality requirements, making domestic benchmarks contemporary with global ones [1].
• Government framing itself positions the initiative as strengthening the quality and credibility of traditional medicines [3].

Export competitiveness

• Importing regulators demand documented, reproducible specifications; a single globally-benchmarked Indian standard eases market access for AYUSH products [1].
• It reduces reliance on foreign certification benchmarks, supporting self-reliance in herbal quality assurance [1].
• Standardised raw-material specifications also aid exchange of scientific information and extracts with international partners [1].

Harmonised pharmacopoeial standards thus convert India's traditional knowledge into a regulatory asset. Sustaining this requires expanding coverage beyond the first 50 herbs, strengthening testing laboratories, and training industry in the new specifications — so that quality assurance, and not merely heritage, becomes the basis of global trust in Indian traditional medicine.